Evidence map›Paper›PMID 34825305›Full record

ArticleInternational urology and nephrology2022

Allicin protects against renal ischemia-reperfusion injury by attenuating oxidative stress and apoptosis.

Maolin Li, Jinzhuo Ning, Houbao Huang, Shuchuan Jiang, Dong Zhuo

Open access · hybridAbstract read
In one paragraph

Article in International urology and nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. m6A demethylase FTO transcriptionally activated by SP1 improves ischemia reperfusion-triggered acute kidney injury by activating Ambra1/ULK1-mediated autophagy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Maolin Li *Department of Urology, Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, People's Republic of China.
Jinzhuo Ning *Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, 430060, People's Republic of China.
Houbao HuangDepartment of Urology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, 241002, People's Republic of China.
Shuchuan JiangDepartment of Urology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, 241002, People's Republic of China.
Dong ZhuoDepartment of Urology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, 241002, People's Republic of China. whzhuo2008@sina.com.ORCID http://orcid.org/0000-0002-6043-2660
First Affiliated Hospital of Wannan Medical College · CNWannan Medical College · CNWuhan University · CNWuxi People's Hospital · CN

Funding

the National Natural Science Foundation of AnHui Province no. 1704f0804046
6 · The paper itself

Abstract

backgroundStudies have demonstrated that allicin may play critical roles in the procession of ischemia-reperfusion(I/R) injury. The purpose of this study was to investigate the protective effects of allicin on renal I/R injury by attenuating oxidative stress and apoptosis.

methodsTo establish a model of renal I/R, the right kidney underwent 12 h reperfusion after 45 min ischemia, allicin was administered intraperitoneally at concentrations of 40, 50 or 60 mg/kg. NRK-52E cells were treated with allicin at concentrations of 1, 3 or 5 μM in 24 h hypoxia/ 6 h reoxygenation(H/R) treatments. Indicators of HE, oxidative stress, apoptosis were measured to evaluate the effect of aliicin on renal I/R injury.

resultsAllicin protected renal I/R injury by ameliorating histological injury and decreasing the oxidative stress in renal tissues. Meanwhile, allicin significantly downregulated the expression of Bax and caspase-3, upregulated the expression of Bcl-2 in I/R renal tissues and H/R treated NRK-52E cells.

conclusionsAllicin may exert anti-apoptotic and antioxidative effects to promote renal function recovery in I/R renal tissues and H/R treated NRK-52E cells. Taken together, allicin may be a potential novel therapy option for future renal injury protection.

Indexed as

Reperfusion InjuryApoptosisDisulfidesHumansIschemiaKidneyOxidative StressSulfinic AcidsallicinDisulfidesSulfinic AcidsAllicinApoptosisReactive Oxygen SpeciesRenal ischemia–reperfusion injury

Identifiers

PMID34825305
PMCPMC9184421
OpenAlexW3216923326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.